IDOX (IDOX) Competitors

IDOX logo
GBX 78.40 0.00 (0.00%)
As of 05/28/2026

IDOX vs. PRSM, KAPE, TRST, KNOS, and FBT

Should you buy IDOX stock or one of its competitors? MarketBeat compares IDOX with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with IDOX include Blue Prism Group (PRSM), Kape Technologies (KAPE), Trustpilot Group (TRST), Kainos Group (KNOS), and First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT). These companies are all part of the "software - application" industry.

How does IDOX compare to Blue Prism Group?

Blue Prism Group (LON:PRSM) and IDOX (LON:IDOX) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, media sentiment, valuation and risk.

IDOX has a net margin of 6.86% compared to Blue Prism Group's net margin of 0.00%. IDOX's return on equity of 7.57% beat Blue Prism Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Blue Prism GroupN/A N/A N/A
IDOX 6.86%7.57%4.20%

IDOX has lower revenue, but higher earnings than Blue Prism Group. Blue Prism Group is trading at a lower price-to-earnings ratio than IDOX, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Blue Prism Group£167.30M0.00N/A-£53.80N/A
IDOX£89.83M4.10£5.56M£1.3458.51

IDOX has a consensus target price of GBX 90, indicating a potential upside of 14.80%. Given IDOX's stronger consensus rating and higher possible upside, analysts clearly believe IDOX is more favorable than Blue Prism Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Blue Prism Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
IDOX
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

6.6% of IDOX shares are held by institutional investors. 9.5% of IDOX shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Blue Prism Group's average media sentiment score of 0.00 equaled IDOX'saverage media sentiment score.

Company Overall Sentiment
Blue Prism Group Neutral
IDOX Neutral

Summary

IDOX beats Blue Prism Group on 10 of the 11 factors compared between the two stocks.

How does IDOX compare to Kape Technologies?

IDOX (LON:IDOX) and Kape Technologies (LON:KAPE) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk.

IDOX has a beta of 0.287, suggesting that its share price is 71% less volatile than the broader market. Comparatively, Kape Technologies has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market.

IDOX currently has a consensus price target of GBX 90, indicating a potential upside of 14.80%. Given IDOX's stronger consensus rating and higher possible upside, equities analysts plainly believe IDOX is more favorable than Kape Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IDOX
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Kape Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

6.6% of IDOX shares are held by institutional investors. Comparatively, 11.4% of Kape Technologies shares are held by institutional investors. 9.5% of IDOX shares are held by insiders. Comparatively, 81.1% of Kape Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, IDOX's average media sentiment score of 0.00 equaled Kape Technologies'average media sentiment score.

Company Overall Sentiment
IDOX Neutral
Kape Technologies Neutral

Kape Technologies has higher revenue and earnings than IDOX. Kape Technologies is trading at a lower price-to-earnings ratio than IDOX, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IDOX£89.83M4.10£5.56M£1.3458.51
Kape Technologies£623.48M0.00£70.92M£0.15N/A

Kape Technologies has a net margin of 11.37% compared to IDOX's net margin of 6.86%. IDOX's return on equity of 7.57% beat Kape Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
IDOX6.86% 7.57% 4.20%
Kape Technologies 11.37%6.97%3.47%

Summary

Kape Technologies beats IDOX on 7 of the 13 factors compared between the two stocks.

How does IDOX compare to Trustpilot Group?

Trustpilot Group (LON:TRST) and IDOX (LON:IDOX) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, risk and dividends.

Trustpilot Group has a beta of 0.49, suggesting that its share price is 51% less volatile than the broader market. Comparatively, IDOX has a beta of 0.287, suggesting that its share price is 71% less volatile than the broader market.

IDOX has a net margin of 6.86% compared to Trustpilot Group's net margin of 2.97%. Trustpilot Group's return on equity of 64.11% beat IDOX's return on equity.

Company Net Margins Return on Equity Return on Assets
Trustpilot Group2.97% 64.11% 1.45%
IDOX 6.86%7.57%4.20%

Trustpilot Group has higher revenue and earnings than IDOX. IDOX is trading at a lower price-to-earnings ratio than Trustpilot Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trustpilot Group£261.05M3.53£20.08M£1.80132.37
IDOX£89.83M4.10£5.56M£1.3458.51

49.5% of Trustpilot Group shares are held by institutional investors. Comparatively, 6.6% of IDOX shares are held by institutional investors. 13.5% of Trustpilot Group shares are held by insiders. Comparatively, 9.5% of IDOX shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Trustpilot Group's average media sentiment score of 0.51 beat IDOX's score of 0.00 indicating that Trustpilot Group is being referred to more favorably in the media.

Company Overall Sentiment
Trustpilot Group Positive
IDOX Neutral

Trustpilot Group presently has a consensus price target of GBX 351.25, suggesting a potential upside of 47.42%. IDOX has a consensus price target of GBX 90, suggesting a potential upside of 14.80%. Given Trustpilot Group's higher probable upside, analysts plainly believe Trustpilot Group is more favorable than IDOX.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Trustpilot Group
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
IDOX
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Trustpilot Group beats IDOX on 11 of the 14 factors compared between the two stocks.

How does IDOX compare to Kainos Group?

Kainos Group (LON:KNOS) and IDOX (LON:IDOX) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment.

38.2% of Kainos Group shares are owned by institutional investors. Comparatively, 6.6% of IDOX shares are owned by institutional investors. 20.3% of Kainos Group shares are owned by insiders. Comparatively, 9.5% of IDOX shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Kainos Group currently has a consensus target price of GBX 1,173.40, suggesting a potential upside of 49.10%. IDOX has a consensus target price of GBX 90, suggesting a potential upside of 14.80%. Given Kainos Group's higher probable upside, equities analysts clearly believe Kainos Group is more favorable than IDOX.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kainos Group
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
IDOX
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Kainos Group has a net margin of 9.86% compared to IDOX's net margin of 6.86%. Kainos Group's return on equity of 41.45% beat IDOX's return on equity.

Company Net Margins Return on Equity Return on Assets
Kainos Group9.86% 41.45% 14.45%
IDOX 6.86%7.57%4.20%

In the previous week, Kainos Group had 1 more articles in the media than IDOX. MarketBeat recorded 1 mentions for Kainos Group and 0 mentions for IDOX. Kainos Group's average media sentiment score of 0.00 equaled IDOX'saverage media sentiment score.

Company Overall Sentiment
Kainos Group Neutral
IDOX Neutral

Kainos Group has higher revenue and earnings than IDOX. Kainos Group is trading at a lower price-to-earnings ratio than IDOX, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kainos Group£431.10M2.10£48.81M£35.1022.42
IDOX£89.83M4.10£5.56M£1.3458.51

Kainos Group has a beta of 0.815, meaning that its stock price is 19% less volatile than the broader market. Comparatively, IDOX has a beta of 0.287, meaning that its stock price is 71% less volatile than the broader market.

Kainos Group pays an annual dividend of GBX 28.90 per share and has a dividend yield of 3.7%. IDOX pays an annual dividend of GBX 0.70 per share and has a dividend yield of 0.9%. Kainos Group pays out 82.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. IDOX pays out 52.2% of its earnings in the form of a dividend.

Summary

Kainos Group beats IDOX on 13 of the 16 factors compared between the two stocks.

How does IDOX compare to First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation?

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) and IDOX (LON:IDOX) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, institutional ownership and profitability.

6.6% of IDOX shares are held by institutional investors. 9.5% of IDOX shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

IDOX has a consensus target price of GBX 90, suggesting a potential upside of 14.80%. Given IDOX's stronger consensus rating and higher possible upside, analysts plainly believe IDOX is more favorable than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
IDOX
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

IDOX has a net margin of 6.86% compared to First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's net margin of 0.00%. IDOX's return on equity of 7.57% beat First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's return on equity.

Company Net Margins Return on Equity Return on Assets
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/A N/A N/A
IDOX 6.86%7.57%4.20%

In the previous week, First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation had 1 more articles in the media than IDOX. MarketBeat recorded 1 mentions for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and 0 mentions for IDOX. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's average media sentiment score of 0.00 equaled IDOX'saverage media sentiment score.

IDOX has higher revenue and earnings than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is trading at a lower price-to-earnings ratio than IDOX, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AN/AN/A-£1.10N/A
IDOX£89.83M4.10£5.56M£1.3458.51

Summary

IDOX beats First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation on 11 of the 12 factors compared between the two stocks.

Get IDOX News Delivered to You Automatically

Sign up to receive the latest news and ratings for IDOX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IDOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IDOX vs. The Competition

MetricIDOXSoftware IndustryComputer SectorLON Exchange
Market Cap£368.55M£4.69B£38.11B£2.78B
Dividend Yield1.00%4.04%3.26%6.16%
P/E Ratio58.5125.7379.39365.72
Price / Sales4.10247.34616.2786,253.69
Price / Cash13.2717.3448.3327.85
Price / Book4.534.239.647.92
Net Income£5.56M£22.26M£1.07B£5.89B
7 Day PerformanceN/A-0.50%-1.41%-0.87%
1 Month Performance5.38%8.89%0.99%-0.76%
1 Year Performance25.44%-10.77%159.21%70.67%

IDOX Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IDOX
IDOX
N/AGBX 78.40
flat
GBX 90
+14.8%
+25.2%£368.55M£89.83M58.51626
PRSM
Blue Prism Group
N/AN/AN/AN/A£1.24B£167.30MN/A1,025
KAPE
Kape Technologies
N/AN/AN/AN/A£1.22B£623.48M1,900.00850
TRST
Trustpilot Group
2.7999 of 5 stars
GBX 245.60
-0.2%
GBX 351.25
+43.0%
+7.6%£949.80M£261.05M136.44820
KNOS
Kainos Group
3.4404 of 5 stars
GBX 815.50
-1.7%
GBX 1,173.40
+43.9%
+4.0%£939.24M£431.10M23.232,953

Related Companies and Tools


This page (LON:IDOX) was last updated on 6/23/2026 by MarketBeat.com Staff.
From Our Partners